Overview
Invenirex, a Newcastle-based biotech, raised £2 million in seed funding led by DSW Ventures, with participation from XTX Ventures and Cambridge Technology Capital. The company’s DNA nanotechnology platform detects diseases earlier than current methods, achieving 200-fold greater sensitivity. Pilot tests have shown promising results in diagnostics and vaccine manufacturing.
Products
Loading...
Recent Deals
Investors: DSW Ventures, XTX Ventures, Cambridge Technology Capital
Invenirex, a Newcastle-based biotech, raised £2 million in seed funding led by DSW Ventures, with participation from XTX Ventures and Cambridge Technology Capital. The company’s DNA nanotechnology platform detects diseases earlier than current methods, achieving 200-fold greater sensitivity. Pilot tests have shown promising results in diagnostics and vaccine manufacturing.